News

The [123I]-E-IACFT Injection (CFT) is an Iodine-123 radiolabeled imaging agent being developed as an aid in the diagnosis of Parkinson’s disease and other movement disorders, with a potential

The patent entitled Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain claims a dosage form for oral transmucosal administration of sufentanil. The patent entitled

Budesonide Inhalation Suspension is the generic equivalent to AstraZeneca’s Pulmicort RESPULES, a maintenance medicine used to control and prevent asthma symptoms in children ages 12 months to eight

BioClinica’s Express EDC solution leverages time-tested, stable technology to provide a central hub to coordinate and organize the collection and dissemination of clean data, adding speed and quality

OmniComm’s eClinical Suite, including the EDC, CTMS, Safety, and Coding solutions, will be used to collect, process, and analyze patient data and adverse events throughout the life of

As part of the revised agreement, Novartis’ optional right to license Idenix’s current and future development-stage drug candidates in any therapeutic area has terminated while it enjoys non-exclusive

The OncoQOL portfolio also includes theDermaQOL product line, with nine personal care products designed to support the skin-care and hair-care needs of cancer patients. OncoQOL is a joint

The study will enroll nearly 240 cataract surgery patients in a two-arm trial, which is designed to evaluate the efficacy and safety of BromSite against the DuraSite vehicle

The complement system, which plays a role in the inflammatory response, becomes activated as a result of tissue damage or microbial infection. The discovery of the mechanism is